| Financial Year |
March 31 2023 |
| Monetary Funds |
1,497,803,535.34 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
9,988,273.33 |
| Accounts Receivable |
2,176,214,642.37 |
| Advances to Suppliers |
1,228,702,798.26 |
| Other Receivables |
95,888,672.41 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
8,478,766,110.79 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
178,733,633.17 |
| Total Current Assets |
14,094,558,985.11 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
11,072,502.68 |
| Investment Properties |
28,215,768.55 |
| Fixed Assetes |
5,788,076,960.56 |
| Under-construction Projects |
468,609,584.04 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,042,074,470.65 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
676,578,307.05 |
| Other Non-Current Assets |
62,693,153.29 |
| Sub-Total of Non-Current Assets |
8,097,320,746.82 |
| Total Assets |
22,191,879,731.93 |
| Short-Term Loans |
1,993,460,142.63 |
| Trading Financial liabilities |
-- |
| Notes Payable |
3,627,322,891.00 |
| Accounts Payable |
744,319,753.16 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
372,662,165.42 |
| Taxes Payable |
326,439,400.75 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
163,748,703.85 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
379,348,483.60 |
| Other Current Liabilities |
197,300,245.73 |
| Sub-Total of Current Liabilities |
9,081,662,257.87 |
| Long-term Loans |
2,460,601,712.72 |
| Bonds Payable |
1,416,984,340.55 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
70,057,083.41 |
| Other Non-Current Liabilities |
200,000,000.00 |
| Sub-Total of Non-Current Liabilities |
4,649,471,663.89 |
| Total Liabilities |
13,731,133,921.76 |
| Paid-In Capital(Or Share Stock) |
690,011,190.00 |
| Capital Surplus |
2,278,871,011.30 |
| Surplus Reserve |
202,903,637.69 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,999,047,045.94 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,460,745,810.17 |
| Owner's Equity（Stockholder's Equity） |
8,460,745,810.17 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
22,191,879,731.93 |
